While Structure Therapeutics Inc ADR has overperformed by 19.18%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GPCR fell by -52.92%, with highs and lows ranging from $62.74 to $13.22, whereas the simple moving average fell by -41.25% in the last 200 days.
On February 28, 2025, William Blair started tracking Structure Therapeutics Inc ADR (NASDAQ: GPCR) recommending Outperform. A report published by Stifel on January 08, 2025, Initiated its previous ‘Buy’ rating for GPCR. H.C. Wainwright also rated GPCR shares as ‘Buy’, setting a target price of $80 on the company’s shares in an initiating report dated December 04, 2024. Morgan Stanley Initiated an Overweight rating on September 23, 2024, and assigned a price target of $118. JP Morgan initiated its ‘Overweight’ rating for GPCR, as published in its report on May 21, 2024. Cantor Fitzgerald’s report from April 09, 2024 suggests a price prediction of $65 for GPCR shares, giving the stock a ‘Overweight’ rating. JMP Securities also rated the stock as ‘Mkt Outperform’.
Analysis of Structure Therapeutics Inc ADR (GPCR)
In order to gain a clear picture of Structure Therapeutics Inc ADR’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -18.61% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 24.74, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 857.30K can be a very valuable indicator of volatility for GPCR stock. On a monthly basis, the volatility of the stock is set at 8.92%, whereas on a weekly basis, it is put at 12.23%, with a gain of 32.42% over the past seven days. Furthermore, long-term investors anticipate a median target price of $78.04, showing growth from the present price of $18.95, which can serve as yet another indication of whether GPCR is worth investing in or should be passed over.
How Do You Analyze Structure Therapeutics Inc ADR Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 4.91%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 102.79% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
GPCR shares are owned by institutional investors to the tune of 102.79% at present.
